Volume 1 Issue 1 - International Biopharmaceutical Industry

Current Edition

Volume 1 Issue 1

Data-driven Decision-making and Real-world Evidence: Current and Emerging Trends

The likelihood of a high-performing drug launch is approximately one in three, meaning that two-thirds of drug launches fall short of expectations. Capturing the full...

15 May 2018 Volume 1 Issue 1

Continue Reading →

Volume 1 Issue 1

New Immunotherapies Need New Models to Reflect New Modalities

Immunotherapy is currently one of the hottest areas in the pharma industry, and development of new targets continues apace. Already, several novel therapeutics have r...

4 May 2018 Volume 1 Issue 1

Continue Reading →

Volume 1 Issue 1

Cognitive Pharmacovigilance: Business Perspective

Among the major functions of a life science company’s pharmacovigilance (PV) department, case management is one of the most resource-intensive processes, involving co...

4 May 2018 Volume 1 Issue 1

Continue Reading →

Volume 1 Issue 1

Transmucosal Drug Delivery to the Brain via the Nose

A recent paper has shown that macromolecules can pass rapidly from the nose into the brain along olfactory nerves, and into the brain and brain stem along branches of...

4 May 2018 Volume 1 Issue 1

Continue Reading →

Volume 1 Issue 1

Inhalation Advances

Respiratory diseases like asthma and chronic obstructive pulmonary disease (COPD) remain the third leading cause of death globally and are growing in prevalence throu...

4 May 2018 Volume 1 Issue 1

Continue Reading →

Volume 1 Issue 1

Zen and the Art of Repurposing Drugs

Once considered a DNA co-purifying annoyance, histone proteins have proven to be an essential component of our genomic makeup. Post-translational modification (PTM) t...

4 May 2018 Volume 1 Issue 1

Continue Reading →

Volume 1 Issue 1

Technology and Business Trends in Gene and Cell Therapies

Investigational Drifts and Technology Synergy Driving Major Opportunities Gene and cell therapies gained industry interest about two decades ago. Since then, a numbe...

4 May 2018 Volume 1 Issue 1

Continue Reading →

Volume 1 Issue 1

Structural Analysis of Biosimilars

The burgeoning field of biosimilars provides opportunities for biopharma and biotech companies to bring lower-cost products to the marketplace more rapidly than is po...

4 May 2018 Volume 1 Issue 1

Continue Reading →

Volume 1 Issue 1

Pushing New Boundaries: Technology and Advanced Analytics in Late-phase Research

Technology and advanced analytics in clinical research is an extremely broad topic and its development is accelerating. Within the clinical research environment, late...

4 May 2018 Volume 1 Issue 1

Continue Reading →

Volume 1 Issue 1

Causes of Improved Patient Retention Rates in Phase IIIa Trials

Phase IIIa trials represent the final stage in determining whether a drug or medical device can make it to market. These trials normally operate at a larger scale tha...

4 May 2018 Volume 1 Issue 1

Continue Reading →